Skip to content

Functional, Dynamic, and Anatomic MR Urography

Functional, Dynamic, and Anatomic MR Urography

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00585767
Enrollment
0
Registered
2008-01-03
Start date
2001-04-30
Completion date
2013-05-31
Last updated
2017-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydronephrosis

Keywords

Hydronephrosis

Brief summary

This is a clinical feasibility study to assess the value of MR imaging for obtaining functional, dynamic and anatomical information in a comprehensive imaging protocol in subjects having obstructive uropathy.

Interventions

None listed

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males or females 18 years of age or older. * All female patients of childbearing potential must agree to use a medically accepted method of contraception at the time of the study. * Patients must have the ability to understand the requirements of the study, provide written and informed consent to participate, and agree to abide by the study requirements. * Patients who have known or suspected hydronephrosis or patients with solitary kidneys.

Exclusion criteria

* Patients with known or suspected hypersensitivity to gadolinium-based agents. * Patients who are pregnant or lactating. * Patients with a condition that is a contraindication to MRI (e.g., cardiac pacemaker, epicardial pacemaker leads, cochlear implants, ferromagnetic aneurysm clip, ferromagnetic halo device, or other conditions that would preclude patient proximity to a strong external magnetic field). * Patients with a recent history of hemolytic anemia, sickle cell anemia or other hemoglobinopathy. * Patients with a history of significant claustrophobia. * Patients with impaired renal function based on 24-hr urine collection (creatinine clearance \<10 ml/min or serum creatinine \>1.8 mg/dl)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026